On June 2, the association joined the Defense Health Research Consortium (DHRC) and its 50 member organizations in a letter to House and Senate appropriators expressing support for the Department of Defense’s Congressional Directed Medical Research Program (CDMRP). CDMRP supports research into deadly and debilitating conditions like cancer, rare diseases such as tuberous sclerosis complex and neurofibromatosis, and conditions disproportionately affecting veterans’ populations such as traumatic brain injury.
The letter noted that “an increase in funding is particularly vital this year to mitigate the impact of the recent spike of inflation on the purchasing power of individual CDMRP programs, particularly those programs that have been flat funded for several years.” The DHRC called on appropriators to increase funding for the CDMRP program by five percent plus inflation. This is necessary to ensure that research programs supported by the program can continue and expand.
The CDMRP is complementary to programs supported by the National Institutes of Health and the Department of Veterans Affairs and focuses on cutting-edge research conducted nowhere else in government. Studies funded by the program are peer-reviewed and subject to a competitive application process. Findings have contributed to numerous treatments and cures and generated economic growth across the United States.
For more information, contact Corbin Evans.